Related Experiment Video

Updated: May 25, 2026

The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma
08:17

The In Ovo Chick Chorioallantoic Membrane (CAM) Assay as an Efficient Xenograft Model of Hepatocellular Carcinoma

Published on: October 9, 2015

Oroxylin A reverses CAM-DR of HepG2 cells by suppressing Integrinβ1 and its related pathway

Binbin Zhu1, Li Zhao, Litao Zhu

  • 1State Key Laboratory of Natural Medicines, Jiangsu Key Laboratory of Carcinogenesis and Intervention, China Pharmaceutical University, 24 Tongjiaxiang, Nanjing 210009, People's Republic of China.

Toxicology and Applied Pharmacology
|February 8, 2012
PubMed

Insights

Oroxylin A reverses chemotherapy resistance in liver cancer cells by inhibiting Integrinβ1. This natural compound enhances Paclitaxel

Area of Science:

  • Pharmacology
  • Cancer Biology
  • Hepatocellular Carcinoma Research

Background:

  • Oroxylin A, a monoflavonoid from Scutellariae radix, demonstrates anticancer properties with low toxicity.
  • Hepatocellular carcinoma (HCC) cells can develop resistance to chemotherapy, a major clinical challenge.
  • The multi-drug resistance (MDR) model in HepG2 cells (CAM-DR HepG2) exhibits reduced sensitivity to cytotoxic agents.

Purpose of the Study:

  • To investigate the role of Integrinβ1 in chemoresistance in the CAM-DR HepG2 cell model.
  • To evaluate the potential of Oroxylin A in reversing Paclitaxel resistance in CAM-DR HepG2 cells.
  • To elucidate the molecular mechanisms underlying Oroxylin A's effect on chemoresistance.

Main Methods:

  • Comparison of drug sensitivity and apoptosis rates between normal HepG2 and CAM-DR HepG2 cells.
  • Assessment of Integrinβ1 expression in CAM-DR HepG2 cells.
  • Evaluation of Oroxylin A treatment effects on Paclitaxel-induced apoptosis and Integrinβ1 signaling pathway using Western blot assays.

Main Results:

  • CAM-DR HepG2 cells showed reduced sensitivity to Paclitaxel and lower apoptosis rates compared to normal HepG2 cells.
  • Increased Integrinβ1 expression was observed in CAM-DR HepG2 cells, and its knockdown enhanced drug sensitivity and apoptosis.
  • Oroxylin A treatment significantly increased Paclitaxel-induced apoptosis in CAM-DR HepG2 cells by down-regulating Integrinβ1 expression and related pathway activity.

Conclusions:

  • Integrinβ1 plays a crucial role in mediating chemoresistance in the CAM-DR HepG2 model.
  • Oroxylin A effectively reverses Paclitaxel resistance in hepatocellular carcinoma cells.
  • Oroxylin A represents a potential therapeutic agent for overcoming drug resistance in cancer treatment.

More Related Videos

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

Related Concept Videos

Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal01:22

Role of Ephrin-Eph Signalling in Intestinal Stem Cell Renewal

Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.